Costello Medical (PRIVATE.COSTELLO)

Overall impact
B (74)

Commentary

Costello Medical is a strong overall performer. With a 'B' rating of 73.6 for overall impact (87th percentile compared to all companies), Costello Medical ranks 17th out of 102 industry peers, behind Bureau Veritas, Bain, Nielsen and 13 others, and ahead of GXP Engaged, Your.Online, Hudson Capital and 82 others. On top material causes for Costello Medical's industry (Professional Services), Costello Medical performs well in Sustainable Use of Natural Resources (92.3 score), Quality Lifelong Education (95.1), Quality Lifelong Education (95.1) and 11 other causes where it received an 'A' score and performs poorly in Safety From Violent Conflict (27.6 score) and Safety From Violent Conflict (27.6).
Impact
Cause PRIVATE.COSTELLO
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2008
Employees
452
Sector
Industrials
Industry
Professional Services
Sub-industry
Research & Consulting Services
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
United Kingdom
Share classes
PRIVATE.COSTELLO
Description
At Costello Medical, we enjoy building lasting partnerships in the healthcare sector by providing exceptional service. Our vision is to be a leading global partner consistently striving for meaningful and outstanding contributions that improve people’s health and lives. Our experts support the healthcare sector in the analysis, interpretation, and communication of clinical and health economic data; our service offerings include evidence development, statistics, health economics, HTA, real-world evidence, market access, medical affairs, publications, and design. We are one of the most established independent agencies delivering medical communications and health economic services. We have grown organically since foundation in 2008 to a team of over 450 based in Cambridge, London, Manchester and Bristol in the UK and internationally in Singapore, China and the US. Our talented team has experience with a variety of leading pharmaceutical and device companies across an extensive range of therapy areas and geographies, including Europe, Asia Pacific, and North America. We are proud to have achieved a 3-star accreditation with Best Companies™ for a sixth consecutive year, and have achieved B Corp certification, showing that we meet the highest standards of verified social and environmental performance.
Material causes
Ethos considers the following causes material for Costello Medical, based on its industry sub-industry Research & Consulting Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.